- Home
- TIC vs ELVN Comparison
TIC vs ELVN Comparison
Compare TIC & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIC
- ELVN
- Stock Information
- Founded
- TIC 1991
- ELVN 2016
- Country
- TIC United States
- ELVN United States
- Employees
- TIC N/A
- ELVN N/A
- Industry
- TIC
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- TIC
- ELVN Health Care
- Exchange
- TIC Nasdaq
- ELVN Nasdaq
- Market Cap
- TIC 1.3B
- ELVN 1.2B
- IPO Year
- TIC N/A
- ELVN 2020
- Fundamental
- Price
- TIC $11.04
- ELVN $18.73
- Analyst Decision
- TIC Hold
- ELVN Strong Buy
- Analyst Count
- TIC 1
- ELVN 5
- Target Price
- TIC $11.50
- ELVN $41.20
- AVG Volume (30 Days)
- TIC 1.6M
- ELVN 400.7K
- Earning Date
- TIC 08-14-2025
- ELVN 08-12-2025
- Dividend Yield
- TIC N/A
- ELVN N/A
- EPS Growth
- TIC N/A
- ELVN N/A
- EPS
- TIC N/A
- ELVN N/A
- Revenue
- TIC $1,108,546,000.00
- ELVN N/A
- Revenue This Year
- TIC $5.80
- ELVN N/A
- Revenue Next Year
- TIC $5.77
- ELVN N/A
- P/E Ratio
- TIC N/A
- ELVN N/A
- Revenue Growth
- TIC 9.12
- ELVN N/A
- 52 Week Low
- TIC $8.76
- ELVN $13.30
- 52 Week High
- TIC $14.28
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- TIC N/A
- ELVN 38.26
- Support Level
- TIC N/A
- ELVN $21.25
- Resistance Level
- TIC N/A
- ELVN $22.83
- Average True Range (ATR)
- TIC 0.00
- ELVN 1.34
- MACD
- TIC 0.00
- ELVN -0.45
- Stochastic Oscillator
- TIC 0.00
- ELVN 8.87
About TIC Acuren Corporation Common Stock
Acuren Corp operates as a provider of critical asset integrity services. The company provides testing, inspection, engineering and lab testing services in different industrial markets such as chemical, pipeline, refinery, power generation, oilsands, automotive, aerospace, mining, manufacturing, renewable energy, and pulp and paper. The company's service line includes Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, etc., Rope Access Technician Solutions (RAT), and Engineering and Lab Testing. The company has two operating and reportable segments, which are the United States, generating maximum revenue, and Canada.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.